SCHEMBL6831908

SCHEMBL6831908

CN(C)c1ccnc(NC2CCC(NC(=O)NCCc3cccc4ccccc34)CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.47
MCHR1 Q99705 13/20 0.42
ADRA2A P08913 7/20 0.40
ADRA1A P35348 2/20 0.39
HRH1 P35367 2/20 0.39
HTR2B P41595 2/20 0.39
FLT3 P36888 2/20 0.39
TYRO3 Q06418 1/20 0.39
MERTK Q12866 1/20 0.39
GAS6 Q14393 1/20 0.39
CDC7 O00311 1/20 0.38
DAPK3 O43293 1/20 0.38
ROCK2 O75116 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
PIM1 P11309 1/20 0.38
PRKACA P17612 1/20 0.38
CDK2 P24941 1/20 0.38
SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6831906 1.00 MTNR1A (0.47) MTNR1AMCHR1ADRA2AADRA1AHRH1
SCHEMBL6456622 0.86 SIGMAR1 (0.48) MCHR1ADRA2ACDK2GSK3BCDK5
SCHEMBL6456613 0.86 SIGMAR1 (0.48) MCHR1ADRA2ACDK2GSK3BCDK5
SCHEMBL6875277 0.82 EPHX1 (0.56) MCHR1
SCHEMBL6875271 0.82 EPHX1 (0.56) MCHR1
SCHEMBL4032879 0.82 MCHR1 (0.61) MTNR1AMCHR1ADRA2AADRA1AHRH1
SCHEMBL4036493 0.82 MCHR1 (0.61) MTNR1AMCHR1ADRA2AADRA1AHRH1
SCHEMBL6877485 0.82 MCHR1 (0.52) MCHR1ADRA2AADRA1AHRH1HTR2B
SCHEMBL6877476 0.82 MCHR1 (0.52) MCHR1ADRA2AADRA1AHRH1HTR2B
SCHEMBL6867769 0.81 MEN1 (0.41) MCHR1ADRA2AFLT3TYRO3MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed